Health News Releases

March 25, 2014 14:00

Oral OTEZLA® (apremilast) Demonstrated Clinically Meaningful and Sustained Improvements in Skin, Nail and Scalp of Adult Patients with Moderate to Severe Plaque Psoriasis

Celgene Corporation (NASDAQ:CELG) today released new research findings on OTEZLA® (apremilast), the Company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), from the ESTEEM 1 and 2 phase III

March 24, 2014 17:00

OTEZLA® (apremilast) - First Oral Therapy Approved by the U.S. Food and Drug Administration for the Treatment of Adults with Active Psoriatic Arthritis

Celgene Corporation (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast), the Company’s oral, selective inhibitor of phosphodiesterase 4 (P

March 24, 2014 10:55

Type 2 Diabetes: CHMP recommends empagliflozin* for approval

Non-US and Non-UK Media Boehringer Ingelheim and Eli Lilly and Company are pleased to announce a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medi

March 24, 2014 10:50

Type 2 Diabetes: New poll of more than 700 Latin American physicians provides insights into complexity and challenges

Boehringer Ingelheim and Eli Lilly and Company today announced results from an online poll of more than 700 physicians treating people with Type 2 Diabetes (T2D) from across six Latin American countri

March 21, 2014 14:55

XPRIZE and TED Announce a Global Competition to Advance Artificial Intelligence

XPRIZE (www.xprize.org), the global leader in incentivized prize competitions, announces today the creation of a prize competition presented by TED, (www.TED.com), the nonprofit devoted to Ideas Worth

March 21, 2014 14:10

High-Speed Ultrasound Beamforming Source Driver From Supertex Delivers Sharper Images for Medical Ultrasound Applications

Supertex (NASDAQ: SUPX), a recognized leader in high voltage analog and mixed signal integrated circuits (ICs), introduces the MD2133, a high-speed source-driver for pulsed current applications. The M

March 20, 2014 09:00

Otsuka and The Union Announce Global TB Research & Innovation Award

In recognition of World TB Day 2014, Otsuka SA (Otsuka), in a global partnership with the International Union Against Tuberculosis and Lung Disease (The Union), today issued a call for nominations for

March 14, 2014 18:05

IntegenX Announces Approval to Upload DNA Profiles From the RapidHIT(TM) System to the National Database

IntegenX Inc., the market leader in Rapid Human DNA identification, has met the FBI guidelines to upload directly to the NDIS system, known arrestee and convicted offender DNA profiles, as well as cas

March 14, 2014 17:35

Clinical study in international headache journal finds electroCore’s non invasive vagus nerve stimulation effective in treating migraine

A study reported (13TH March 2014) in the International Headache Society’s official journal Cephalalgia found that the use of electroCore’s non invasive vagus nerve stimulation therapy (nVNS) may be a

March 14, 2014 17:35

Quintiles Announces Pricing of Secondary Public Offering

Quintiles today announced the pricing of a secondary public offering of 15 million shares of its common stock by certain of its shareholders at a price to the public of $52.00 per share. In addition,

March 13, 2014 15:20

STC life, Co., Ltd. Successfully Treats Canadian Pulmonary Fibrosis Patient at 97.7 B&H Hospital Stem Cell Center

Stem cell research institute of STC Life Co., Ltd. (http://stclife.com/en/lab/lnb01.html) (Chairman: KYE HO LEE) and 97.7 B&H Clinic (Representative Doctor: WON JU JUNG) successfully finished mesenchy

March 12, 2014 17:20

Quintiles Honored as ‘Best CRO in Asia’ for 3rd Time in Four Years

Quintiles last night was named the “Best CRO in Asia” at the 2014 BioPharma Asia Industry Awards dinner, the third time in the event’s four-year history that Quintiles has received the honor. The awar

March 12, 2014 17:00

Mentor Capital Acquires 60% of Bhang Chocolate for $39 Million

Mentor Capital, Inc. (OTC Markets: MNTR) announced today that it has been selected by Bhang Chocolate Company, Inc. to provide $39 Million in equity funding for Bhang’s national and international expa

March 11, 2014 15:55

Quintiles Announces Launch of Secondary Public Offering of Common Stock

Quintiles Transnational Holdings Inc. (“Quintiles”) (NYSE:Q) announced today the launch of a secondary public offering of its common stock. Certain shareholders of Quintiles (the “Selling Shareholders

March 11, 2014 13:00

ResearchDx, the Leading Contract Diagnostics Organization, Sponsors the Asia BioPharma Convention 2014

ResearchDx, LLC of Irvine, California, USA today announced its sponsorship and attendance at the Asia BioPharm 2014 Convention in Singapore as part of its focus on the important Asian biopharmaceutica

March 07, 2014 18:45

22nd Century Group Approved to List Common Stock on NYSE MKT

22nd Century Group, Inc. (OTCQB:XXII) today announced that the Company received approval to list its common stock on the NYSE MKT. Trading on the NYSE MKT is expected to commence on Tuesday, March 11,

March 07, 2014 18:00

Pradaxa® (dabigatran etexilate) now approved in over 100 countries for stroke prevention in atrial fibrillation

For media outside of the US, the UK & Canada only Over 100 countries have now approved Boehringer Ingelheim’s Pradaxa® for the prevention of stroke and systemic embolism for adult patients with the

March 07, 2014 15:00

SecondOpinions.com Releases Innovative Mobile Application to Android and Apple Stores Featuring Patent Pending Automated Algorithm to Assess & Predict Risk of Disease

USARAD Holdings Inc., a leading U.S. Joint Commission Accredited teleradiology and telemedicine solutions provider recently released a new version of SecondOpinions.com featuring Web 2.0 technology. T

March 07, 2014 10:36

Omega-3 Polyunsaturated Fatty Acids (PUFAs) - 2014 Global Market Overview with Company Profiles on 42 Key Global Players in the Industry

Research and Markets (http://www.researchandmarkets.com/research/5s52t7/omega3) has announced the addition of the “Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview” report to the

March 06, 2014 16:35

Independent Study Shows V.A.C. VeraFlo™ Therapy More Beneficial Than Traditional V.A.C.® Therapy

Kinetic Concepts, Inc. (www.KCI1.com) today announced an independent, retrospective study published in Plastic and Reconstructive Surgery showed that adjunctive treatment with V.A.C. VeraFlo™ Therapy,

March 06, 2014 13:24

The Microfluidics Market: Report Segments Market By Materials, Pharmaceuticals, Drug Delivery Devices, IVD - Global Trends & Forecast to 2018 and Company Profiles on Industry Leaders Included

Research and Markets (http://www.researchandmarkets.com/research/wvzpv6/microfluidics) has announced the addition of the “Microfluidics Market By Materials, Pharmaceuticals, Drug Delivery Devices, IVD

March 06, 2014 13:10

Rehabilitation Robots, Active Prostheses, and Exoskeletons Report - Includes Market Shares, Strategies, Company Profiles of Market Leaders and Worldwide Forecasts for 2014 to 2020

Research and Markets (http://www.researchandmarkets.com/research/b6v8tv/rehabilitation) has announced the addition of the new report “Rehabilitation Robots, Active Prostheses, and Exoskeletons - Marke

March 04, 2014 22:00

Harlan Contract Research Services (CRS) and Bertin Pharma Sign Strategic Collaboration Agreement

Harlan Contract Research Services (http://goo.gl/At862O) and Bertin Pharma (www.bertinpharma.com/), headquartered in Montigny-le-Bretonneux, France, announced a strategic partnership to offer a compre